U.S. Markets closed

SMC posts decision on Kalydeco resubmission to website

The Scottish Medicines Consortium completed its assessment of Vertex Pharmaceuticals' resubmission for Kalydeco and posted its advice to the SMC website on June 10. Following a resubmission, Kalydeco is not recommended for use within NHS Scotland, the body stated.